Abstract #0051
19F MRI for Evaluating ERK1 as a Factor Regulating Dendritic Cell Migration in High Grade Glioma
Min-Chi Ku 1 , Martin Gnther 1 , Conrad Martin 1 , Stefano Lepore 1 , Helmar Waiczies 1,2 , Andreas Pohlmann 1 , Susanne A. Wolf 3 , Helmut Kettenmann 3 , Thoralf Niendorf 1 , and Sonia Waiczies 1
1
Berlin Ultrahigh Field Facility (B.U.F.F.),
Max Delbrck Center for Molecular Medicine, Berlin,
Germany,
2
MRI.TOOLS
GmbH, Berlin, Berlin, Germany,
3
Cellular
Neurosciences, Max Delbrck Center for Molecular
Medicine, Berlin, Germany
Immunotherapy with dendritic cell based vaccines for
treating glioma has become one attractive approach. To
access the efficiency of DC vaccine, it is necessary to
monitor the distribution of DCs in the CNS or lymphoid
organs. Our goal is to target molecules, which are
involved in regulating DCs within the glioma context. In
this study we found that deficiency of ERK1 result in
tumor regression. 19F/1H MRI monitored the migration of
DCs and found that ERK1 can regulate DC migration.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
